Sylvain Ladoire

11PUBLICATIONS
40CO-AUTHORS
Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 23, 2024
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).

Nicholas Turner, Cristina Saura, Philippe Aftimos

|Jul 31, 2024
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides.

Erik N Bergstrom, Ammal Abbasi, Marcos Díaz-Gay

|Jan 23, 2024
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience.

Jérémy Baude, Julie Niogret, Pierre Jacob

|Nov 06, 2023
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.

François-Clément Bidard, Nicolas Kiavue, William Jacot

|Aug 10, 2023
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.

Silvia Mihaela Ilie, Nathalie Briot, Guillaume Constantin

|Apr 28, 2023
Performance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular Carcinoma.

David Bonnin, Sylvain Ladoire, Nathalie Briot

Pageof 2

Frequent Collaborators

3 joint publications

François Ghiringhelli

1 joint publications

Delphine Hudry

1 joint publications

Samuel Meignan

1 joint publications

Houssein El Hajj